| Literature DB >> 32810303 |
I Martínez-Pallás1, B Aldea-Manrique1, M Ramírez-Lluch1, J Manuel Vinuesa-Hernando2, M Ara-Martín1.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32810303 PMCID: PMC7461221 DOI: 10.1111/jdv.16879
Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN: 0926-9959 Impact factor: 9.228
Comparison of demographic, clinical and therapeutic data between scabies cases diagnosed during the months of confinement and non‐confinement
| Confinement | No confinement | Statistical comparison | |
|---|---|---|---|
| N | 64 | 93 | |
| Gender | |||
| Male | 32 | 48 | χ2 (1) = 0.01, |
| Female | 32 | 45 | |
| Age (mean + SD) | 30.87 ± 21.28 | 32.16 ± 25.11 |
|
| Cohabitants + | 52 (81.25%) | 61 (65.59%) | χ2 (1) = 3.865, |
| Family Cluster | 35 (54.68%) | 18 (19.35%) | χ2 (1) = 19.61, |
| Symptoms duration | 9.75 ± 5.85 | 5.77 ± 5.172 | ( |
| Previous treatment | 48 (75%) | 14 (15.05%) | χ2 (1) = 54.53, |
| Treatment with permethrin | 64 (100%) | 93 (100%) | |
| Previous applications of permethrin (mean + SD) | 4.10 ± 2.94 | 1.64 ± 0.84 |
|
| Treatment with ivermectin | 36 (60.93%) | 4 (4.3%) | χ2 (1) = 58.33, |
Period between March and May 2020.
Period between March and May from 2015 to 2019.
Figure 1Home confinement effect on scabies infestation.